Talbot, Jhimmy
Hahn, Paul
Kroehling, Lina
Nguyen, Henry
Li, Dayi
Littman, Dan R.
Article History
Received: 11 July 2019
Accepted: 13 January 2020
First Online: 12 February 2020
Competing interests
: D.R.L. consults and has equity interest in Chemocentryx, Vedanta, and Pfizer Pharmaceuticals. All other authors declare no competing interests.